| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Werner Sean | Chief Technology Officer | 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL | /s/ Sean Werner | 26 Feb 2026 | 0002047541 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLFS | Common Stock | Award | +24,116 | +93% | 50,043 | 24 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation. |